Conca, Francesca
Esposito, Valentina
Catricalà, Eleonora
Manenti, Rosa
L’Abbate, Federica
Quaranta, Davide
Giuffrè, Guido Maria
Rossetto, Federica
Solca, Federica
Orso, Beatrice
Inguscio, Emanuela
Crepaldi, Valeria
De Matteis, Maddalena
Rotondo, Emanuela
Manera, Marina
Caruso, Giulia
Catania, Valentina
Canu, Elisa
Rundo, Francesco
Cotta Ramusino, Matteo
Filippi, Massimo
Fundarò, Cira
Piras, Federica
Arighi, Andrea
Tiraboschi, Pietro
Stanzani Maserati, Michelangelo
Pardini, Matteo
Poletti, Barbara
Silani, Vincenzo
Marra, Camillo
Di Tella, Sonia
Cotelli, Maria
Lodi, Raffaele
Tagliavini, Fabrizio
Cappa, Stefano Francesco
Article History
Received: 20 October 2023
Accepted: 21 April 2024
First Online: 4 May 2024
Declarations
:
: The study was approved by the local ethics committees (Ethic committee of Pavia, IRCCS Policlinico “San Matteo”, Pavia, Italy) and complied with the provisions of the Declaration of Helsinki. All subjects gave written informed consent to participate.
: Not applicable.
: V. Silani received compensation for consulting services and/or speaking activities from AveXis, Cytokinetics, Italfarmaco, Liquidweb S.r.l., Novartis Pharma AG and Zambon Biotech SA; he receives or has received research supports form the Italian Ministry of Health, AriSLA, E-Rare Joint Transnational Call, and the ERN Euro-NMD. He is in the Editorial Board of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, European Neurology, American Journal of Neurodegenerative Diseases, Frontiers in Neurology, and Exploration of Neuroprotective Therapy. E. Canu receives research supports from the Italian Ministry of Health. M. Filippi is Editor-in-Chief of the Journal of Neurology, Associate Editor of Human Brain Mapping, Neurological Sciences, and Radiology; he received compensation for consulting services from Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi and for speaking activities from Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA; participation in Advisory Boards for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda; scientific direction of educational events for Biogen, Merck, Roche, Celgene, Bristol-Myers Squibb, Lilly, Novartis, Sanofi-Genzyme; he receives research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.